Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
2.
Nutr Metab Cardiovasc Dis ; 30(11): 2085-2092, 2020 10 30.
Article in English | MEDLINE | ID: mdl-32807637

ABSTRACT

BACKGROUND AND AIMS: Data from animals suggest that immunoglobulins G (IgG) play a mechanistic role in atherosclerosis and diabetes through endothelial dysfunction and insulin resistance. Patients with common variable immunodeficiency (CVID), who have low circulating levels of IgG and are treated with intravenous polyclonal IgG (IVIgG), may provide an ideal model to clarify whether circulating IgG modulate endothelial function and affect insulin sensitivity in humans. METHODS AND RESULTS: We studied 24 patients with CVID and 17 matched healthy controls (HC). Endothelial function was evaluated as flow mediated dilation (FMD) of the brachial artery at baseline and 1, 7, 14, and 21 days after IVIgG infusion in the CVID patients. We measured also plasma glucose, insulin, and calculated the HOMA-IR index. We also investigated the role of human IgG on the production of Nitric Oxide (NO) in vitro in Human Coronary Artery Endothelial Cells (HCAEC). Compared to HC, FMD of CVID patients was significantly impaired at baseline (9.4 ± 0.9 and 7.6 ± 0.6% respectively, p < 0.05) but rose above normal levels 1 and 7 days after IVIgG infusion to return at baseline at 14 and 21 days. Serum insulin concentration and HOMA-IR index dropped by 50% in CVID patients after IVIgG (p < 0.002 vs. baseline). In vitro IgG stimulated NO production in HCAEC. CONCLUSIONS: Reduced IgG levels are associated with endothelial dysfunction and IVIgG stimulates endothelial function directly while improving insulin sensitivity. The current findings may suggest an anti-atherogenic role of human IgG.


Subject(s)
Brachial Artery/drug effects , Common Variable Immunodeficiency/drug therapy , Endothelium, Vascular/drug effects , Immunoglobulin G/administration & dosage , Immunoglobulins, Intravenous/administration & dosage , Insulin Resistance , Vasodilation/drug effects , Adolescent , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Brachial Artery/metabolism , Brachial Artery/physiopathology , Case-Control Studies , Cells, Cultured , Common Variable Immunodeficiency/blood , Common Variable Immunodeficiency/physiopathology , Endothelium, Vascular/metabolism , Endothelium, Vascular/physiopathology , Female , Humans , Infusions, Intravenous , Insulin/blood , Male , Nitric Oxide/metabolism , Time Factors , Treatment Outcome , Young Adult
3.
Monaldi Arch Chest Dis ; 87(3): 838, 2017 09 28.
Article in English | MEDLINE | ID: mdl-29424197

ABSTRACT

Pregabalin, widely used in the treatment of several pain disorders, is usually well tolerated. Uncommonly, the drug may induce cardiac side effects, rarely prolongation of the PR interval. The latter has never been described in patients with healthy heart or normal renal function. We characterize a unique case of a young man with extrapulmonary tuberculosis and no detectable or known cardiac or kidney diseases, treated with pregabalin to control the severe pain due to the involvement of the spinal cord by the tuberculosis, showing an atrioventricular (AV) block due to pregabalin administration. The reported case emphasizes the need of monitoring PR interval during treatment with pregabalin, even in patients without background of cardiac or renal diseases.


Subject(s)
Atrioventricular Block/chemically induced , Pain/drug therapy , Pregabalin/adverse effects , Tuberculosis, Central Nervous System/complications , Atrioventricular Block/physiopathology , Calcium Channel Blockers/administration & dosage , Calcium Channel Blockers/adverse effects , Calcium Channel Blockers/therapeutic use , Electrocardiography/instrumentation , Humans , Male , Pregabalin/administration & dosage , Pregabalin/therapeutic use , Treatment Outcome , Tuberculosis, Central Nervous System/diagnostic imaging , Tuberculosis, Central Nervous System/drug therapy , Tuberculosis, Central Nervous System/pathology , Young Adult
4.
World J Cardiol ; 5(10): 375-81, 2013 Oct 26.
Article in English | MEDLINE | ID: mdl-24198907

ABSTRACT

AIM: To clarify whether the vasoconstrictory response is impaired and to study vascular function in patients with migraine during the headache attack. METHODS: We studied vascular reactivity in the resistance arteries by using the forearm perfusion technique associated with plethysmography. We measured forearm blood flow by strain-gauge plethysmography during intra-brachial infusion of acetylcholine, sodium nitroprusside or norepinephrine in 11 controls and 13 patients with migraine, 11 of them (M) in the interval between the migraine attacks and 4 during a headache attack (MH). Written informed consent was obtained from patients and healthy controls, and the study was approved by the Ethics Committee of the University Federico II. RESULTS: Compared to healthy control subjects, in patients with migraine studied during the interictal period, the vasodilating effect of acetylcholine, that acts through the stimulation of endothelial cells and the release of nitric oxide, was markedly reduced, but became normal during the headache attack (P < 0.05 by analysis of variance). The response to nitroprusside, which directly relaxes vascular smooth muscle cells (VSMCs), was depressed in patients with migraine studied during the interictal period, but normal during the headache attack (P < 0.005). During norepinephrine infusion, forearm blood flow decreased in control subjects (-40% ± 5%, P < 0.001). In contrast, in patients with migraine, either when studied during or free of the headache attack forearm blood flow did not change compared to the baseline value (-3% ± 13% and -10.4% ± 15%, P > 0.05). CONCLUSION: In migrainers, the impaired relaxation of VSMCs is restored during the headache attack. The vasoconstrictory response is impaired and remains unchanged during the migraine attack.

5.
J Health Econ ; 30(6): 1197-206, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21974868

ABSTRACT

We study optimal public health care rationing and private sector price responses. Consumers differ in their wealth and illness severity (defined as treatment cost). Due to a limited budget, some consumers must be rationed. Rationed consumers may purchase from a monopolistic private market. We consider two information regimes. In the first, the public supplier rations consumers according to their wealth information (means testing). In equilibrium, the public supplier must ration both rich and poor consumers. Rationing some poor consumers implements price reduction in the private market. In the second information regime, the public supplier rations consumers according to consumers' wealth and cost information. In equilibrium, consumers are allocated the good if and only if their costs are below a threshold (cost effectiveness). Rationing based on cost results in higher equilibrium consumer surplus than rationing based on wealth.


Subject(s)
Health Care Costs , Health Care Rationing/economics , Health Care Sector/organization & administration , Health Services Accessibility/economics , Budgets , Consumer Behavior , Costs and Cost Analysis , Health Care Rationing/methods , Humans , Models, Econometric , Private Sector/economics , Public Health/economics
6.
J Pharm Biomed Anal ; 38(4): 738-45, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15967302

ABSTRACT

A simple and fast analytical method using hydrophilic interaction liquid chromatography (HILIC) coupled with mass spectrometry was developed to analyse 5-fluorouracil (5-FU) in plasma and tissues. The HILIC system overcomes problems reported in obtaining satisfactory retention of 5-FU with other types of HPLC systems. After addition of internal standard (IS) (5-Chlorouracil (5-CU)), plasma proteins were precipitated with acetonitrile, and tissue samples homogenised with a micro-dismembrator. The analysis was performed using a polymer-based column (Ashaipak NH2) and the compounds were eluted under gradient conditions at 1 ml/min using a mobile phase containing a mixture of ammonium formate and acetonitrile. MS detection used a API 4000 mass spectrometry with heated nebulizer source and multiple reaction monitoring operated in the negative ion mode. The mass transitions of 5-FU and its internal standard were 129 m/z-->42m/z and 145 m/z-->42 m/z, respectively. The lower limits of quantitation in plasma and tissues were about 5 ng/ml and 10 ng/g, respectively, using 25 microl of plasma and 50mg of tissue. Good linearity, accuracy and precision were obtained in all matrices tested. The suitability and robustness of the method for in vivo samples were confirmed by analysis of mouse plasma, muscle and tumour from animals dosed with 5-FU.


Subject(s)
Antimetabolites/analysis , Fluorouracil/analysis , Animals , Antimetabolites/blood , Antimetabolites/pharmacokinetics , Calibration , Chemical Phenomena , Chemistry, Physical , Chromatography, Liquid , Fluorouracil/blood , Fluorouracil/pharmacokinetics , Mass Spectrometry , Mice , Reference Standards , Tissue Distribution , Uracil/analogs & derivatives , Uracil/analysis , Uracil/blood , Uracil/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...